Akelos Inc. Announces United States Patent and Trademark Office Allowance of Patent Claiming its Lead Compound

Akelos Inc., a biotechnology company currently developing and commercializing a novel, non-opioid anti- hyperalgesic drug to treat chronic and neuropathic pain.

Related Keywords

United States ,Peter Goldstein ,Steven Fox ,Trademark Office ,Akelos Inc ,Us Patent Office ,United States Patent ,Weill Cornell Medicine ,Akelos Founder ,Scientific Advisory ,Chronic Pain ,Non Opioid Drug ,Non Addictive Drug ,